BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage

Information Letter on Tasigna®
active substance: nilotinib

2009.09.15

Active substance: nilotinib

The Federal Institute for Drugs and Medical Devices (BfArM) requests consideration of the Information letter concerning the medicinal product Tasigna® (active substance: nilotinib)

Information Letter on Tasigna®
active substance: nilotinib PDF, 915KB, File does not meet accessibility standards